Concepedia

Author

Mario Widel

Eli Lilly (United States)

Also Known As

M. Widel, Mario H. Widel, Mario Widel, S. Uçak

18

Publications

1.2K

Citations

8

H-Index

6

Concepts

All Affiliations

Eli Lilly (United States)Takeda (United Kingdom)
MW

About

Mario Widel is an author at Eli Lilly (United States) specializing in medicine, obesity, and diabetes.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

93

2

Diabetes

1

1

93

3

Pharmacology

1

1

93

4

Obesity

1

1

93

5

Metabolic Syndrome

1

1

93

Mario Widel

×

6

Publications

1.1K

Citations

6

H-Index

YearCitations

Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes

Robert J. Heine, Luc F. Van Gaal, Don Johns,

Annals of Internal Medicine

2005

794

Expression of a Mutant Form of the Ferritin Light Chain Gene Induces Neurodegeneration and Iron Overload in Transgenic Mice

Rubén Vidal, Leticia Miravalle, Xiaoying Gao,

Journal of Neuroscience

2008

108

Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study

Vinod Mattoo, D.J.A. Eckland, Mario Widel,

Clinical Therapeutics

2005

93

Comparison of Effect of Pioglitazone With Metformin or Sulfonylurea (Monotherapy and Combination Therapy) on Postload Glycemia and Composite Insulin Sensitivity Index During an Oral Glucose Tolerance Test in Patients With Type 2 Diabetes

Antonio Ceriello, Don Johns, Mario Widel,

Diabetes Care

2005

70

Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes

Meng H. Tan, N. Bradly Glazer, Don Johns,

Current Medical Research and Opinion

2004

25

Long‐term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus

Michael Roden, Markku Laakso, Don Johns,

Diabetic Medicine

2005

22

Page 1